Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Health Canada ends FSRN Process

Feb 24, 2026

A Foreign Site Reference Number (FSRN) is generally issued by Health Canada to foreign sites that manufacture, package, or label Natural Health Products (NHPs). It confirms partial compliance with GMP requirements under Part 3 of the NHP regulations. A FSRN is not...

New FDA Draft Guidance: Records Access for Cosmetics Under MoCRA

Feb 13, 2026

The U.S. Food and Drug Administration (FDA) has released a new draft guidance titled ‘Records Access for Cosmetics’. This publication marks another step in the ongoing implementation of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Purpose and Scope:...

Arizona Introduces SB 1005 to Ban Cosmetic Animal Testing

Feb 13, 2026

The landscape of cosmetic regulation in the United States continues to evolve. The Arizona State Senate has officially introduced SB 1005, a bill that seeks to prohibit the use of animal testing for cosmetic products within the state. If enacted, this legislation...

California DTSC Finalizes MMA Regulation for Nail Products

Feb 13, 2026

The California Department of Toxic Substances Control (DTSC) has officially finalized new regulations under the Safer Consumer Products (SCP) program, targeting methyl methacrylate (MMA) in nail products. If your company manufactures nail coatings or artificial nails...

FDA Announces Fiscal Year 2026 OMOR Fee Rates: Costs to Increase

Feb 13, 2026

The U.S. Food and Drug Administration (FDA) has officially released the fee rates for Over-the-Counter (OTC) Monograph Order Requests (OMOR) for the upcoming Fiscal Year (FY) 2026. As the OTC landscape continues to evolve under the CARES Act reforms, manufacturers and...

FDA Releases Draft Guidance on Mandatory Cosmetics Recalls under MoCRA

Feb 13, 2026

The U.S. Food and Drug Administration (FDA) has published a significant new draft guidance document titled ‘Questions and Answers Regarding Mandatory Cosmetics Recalls: Guidance for Industry.’ This release is a key step in implementing the Modernization of Cosmetics...

Washington State Update: Mandatory PCR Reporting Begins for Personal Care Products

Feb 13, 2026

The Washington State Department of Ecology has officially opened the 2026 Plastic Producer Registration and Reporting Cycle. While annual registration applies to all producers, this cycle marks a significant compliance milestone specifically for the Personal Care and...

SB 54 Update: CalRecycle Releases Updated CMC List & First-Ever Recycling Rates

Feb 13, 2026

CalRecycle has officially published the annual update to the Covered Material Categories (CMC) list under California’s SB 54 (Plastic Pollution and Packaging Producer Responsibility Act). This update, effective Jan 2026, is critical for determining if your packaging...

FDA Release: The State of PFAS in Cosmetics Under MoCRA

Feb 13, 2026

Following the mandates set by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), the U.S. FDA has released its latest report on perfluoroalkyl and polyfluoroalkyl substances (PFAS) in beauty and personal care products. Based on mandatory industry filings,...

CARB Launches 2025 Personal Fragrance Technical Assessment

Feb 13, 2026

If you manufacture or sold personal fragrance products with 10 percent or less fragrance in 2025 products in the California market, it is time to prepare for the latest technical assessment from the California Air Resource Borad (CARB). CARB is currently evaluating...

« Older Entries

“Focal Point Research has consistently and professionally looked after regulatory and quality issues of our brand for years. Through a courteous and knowledgeable team, they have managed to navigate us through an ever changing regulatory landscape while maintaining our interests, and allowed us to correctly distribute and sell within Canada.”

“I have truly enjoyed working with you over the last 8 years! You and your team have been an amazing resource for me. I have always been impressed by the knowledge and professionalism of everyone at Focal Point, which is a true testament to your leadership.”

Connect With Us

The Focal Point Research team is ready to help with all of your scientific and regulatory needs. Our team has the experience and expertise you need to see your product to market and we are eager to help you.

181 Lakeshore Road E. Mississauga, ON

1 (905) 271 2709

mail@focalpointresearch.net

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Connect With Us